Branded Generics Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Application, By Drug Class, By Consumption Type, By Distribution Channel, By Country, & By Region

  • Report Id: HCDHR 2397
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Branded Generics Market Report Overview

Branded Generics market garnered a revenue of USD 245.71 billion in the year 2019 globally and has been foreseen to yield USD 431.59 million by the year 2027 at a compound annual growth (CAGR) of 8.1% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Branded Generics market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Branded Generics Total Available Market (TAM) Size
  • Branded Generics Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Branded Generics Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Branded Generics Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Branded Generics Market: Application Insights
4.1. Global Application Historic Market Data & Future Forecasts, 2016-2027
4.2. Oncology
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Cardiovascular Diseases
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Diabetes
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Neurology
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Branded Generics Market: Drug Class Insights
5.1. Global Drug Class Historic Market Data & Future Forecasts, 2016-2027
5.2. Anti-Hypertensive
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Antimetabolites
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.4. Lipid Lowering Drugs
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Others
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Branded Generics Market: Consumption Type Insights
6.1. Global Consumption Type Historic Market Data & Future Forecasts, 2016-2027
6.2. Oral
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.3. Parenteral
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
6.4. Topical
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.5. Others
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 7. Branded Generics Market: Distribution Channel Insights
7.1. Global Distribution Channel Historic Market Data & Future Forecasts, 2016-2027
7.2. Hospital Pharmacies
7.2.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
7.3. Retail Pharmacies
7.3.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
7.4. Online Pharmacies
7.4.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
7.5. Other Pharmacies
7.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 8. Branded Generics Market: Regional Insights
8.1. Global Branded Generics Market Data & Future Forecasts, By Region 2016-2027
8.2. North America
8.2.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.2.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.2.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.2.6. U.S.
8.2.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.2.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.2.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.2.7. Canada
8.2.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.2.7.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.2.7.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.3. Europe
8.3.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.3.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.3.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.3.6. U.K.
8.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.3.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.3.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.3.7. Germany
8.3.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.3.7.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.3.7.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.3.8. France
8.3.8.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.8.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.8.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.3.8.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.3.8.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.4. Asia Pacific
8.4.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.4.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.4.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.4.6. China
8.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.4.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.4.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.4.7. India
8.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.4.7.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.4.7.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.4.8. Japan
8.4.8.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.8.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.8.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.4.8.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.4.8.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.4.9. South Korea
8.4.9.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.9.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.9.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.4.9.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.4.9.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.5. Latin America
8.5.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.5.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.5.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.5.6. Brazil
8.5.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.5.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.5.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.5.7. Mexico
8.5.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.5.7.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.5.7.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.6. Middle East & Africa
8.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.6.6. UAE
8.6.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.6.6.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.6.6.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
8.6.7. South Africa
8.6.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
8.6.7.4. Historic Market Data & Future Forecasts, By Consumption Type, 2016-2027
8.6.7.5. Historic Market Data & Future Forecasts, By Distribution Channel, 2016-2027
Chapter 9. Company Profiles
9.1. Zydus Cadila
9.1.1. Company Description
9.1.2. Financial Highlights
9.1.3. Product Portfolio
9.1.4. Strategic Initiatives
9.2. Hetero
9.2.1. Company Description
9.2.2. Financial Highlights
9.2.3. Product Portfolio
9.2.4. Strategic Initiatives
9.3. AstraZeneca
9.3.1. Company Description
9.3.2. Financial Highlights
9.3.3. Product Portfolio
9.3.4. Strategic Initiatives
9.4. Mylan N.V.
9.4.1. Company Description
9.4.2. Financial Highlights
9.4.3. Product Portfolio
9.4.4. Strategic Initiatives
9.5. Novartis AG
9.5.1. Company Description
9.5.2. Financial Highlights
9.5.3. Product Portfolio
9.5.4. Strategic Initiatives
9.6. Pfizer Inc.
9.6.1. Company Description
9.6.2. Financial Highlights
9.6.3. Product Portfolio
9.6.4. Strategic Initiatives
9.7. GlaxoSmithKline plc
9.7.1. Company Description
9.7.2. Financial Highlights
9.7.3. Product Portfolio
9.7.4. Strategic Initiatives
9.8. Aspen Holdings
9.8.1. Company Description
9.8.2. Financial Highlights
9.8.3. Product Portfolio
9.8.4. Strategic Initiatives
9.9. Bausch Health
9.9.1. Company Description
9.9.2. Financial Highlights
9.9.3. Product Portfolio
9.9.4. Strategic Initiatives
9.10. Lifesciences Limited
9.10.1. Company Description
9.10.2. Financial Highlights
9.10.3. Product Portfolio
9.10.4. Strategic Initiatives
List of Tables
Table 1 Branded Generics Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Branded Generics Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 4 Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 5 Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 6 Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 7 Oncology Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Cardiovascular Diseases Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Diabetes Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Neurology Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Anti-Hypertensive Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 Antimetabolites Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Lipid Lowering Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 Oral Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 Parenteral Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 Topical Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 19 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 Hospital Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 Retail Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 22 Online Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 23 Other Pharmacies Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 24 North America Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 25 North America Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 26 North America Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 27 North America Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 28 North America Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 29 U.S. Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 30 U.S. Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 31 U.S. Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 32 U.S. Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 33 U.S. Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 34 Canada Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 35 Canada Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 36 Canada Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 37 Canada Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 38 Canada Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 39 Europe Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 40 Europe Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 41 Europe Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 42 Europe Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 43 Europe Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 44 U.K. Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 45 U.K Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 46 U.K Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 47 U.K Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 48 U.K Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 49 Germany Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 50 Germany Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 51 Germany Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 52 Germany Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 53 Germany Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 54 France Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 55 France Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 56 France nada Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 57 France Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 58 France Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 59 Asia Pacific Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 60 Asia Pacific Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 61 Asia Pacific Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 62 Asia Pacific Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 63 Asia Pacific Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 64 China Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 65 China Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 66 China Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 67 China Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 68 China Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 69 India Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 70 India Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 71 India Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 72 India Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 73 India Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 74 Japan Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 75 Japan Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 76 Japan Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 77 Japan Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 78 Japan Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 79 South Korea Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 80 South Korea Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 81 South Korea Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 82 South Korea Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 83 South Korea Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 84 Latin America Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 85 Latin America Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 86 Latin America Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 87 Latin America Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 88 Latin America Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 89 Brazil Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 90 Brazil Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 91 Brazil Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 92 Brazil Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 93 Brazil Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 94 Mexico Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 95 Mexico Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 96 Mexico Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 97 Mexico Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 98 Mexico Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 99 Middle East & Africa Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 100 Middle East & Africa Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 101 Middle East & Africa Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 102 Middle East & Africa Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 103 Middle East & Africa Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 104 UAE Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 105 UAE Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 106 UAE Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 107 UAE Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 108 UAE Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
Table 109 South Africa Branded Generics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 110 South Africa Branded Generics Market Data & Future Forecasts, By Application, 2016-2027 (USD Billion)
Table 111 South Africa Branded Generics Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 112 South Africa Branded Generics Market Data & Future Forecasts, By Consumption Type, 2016-2027 (USD Billion)
Table 113 South Africa Branded Generics Market Data & Future Forecasts, By Distribution Channel, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Branded Generics Market, by 2016-2027 (USD Billion)
Fig.3 Branded Generics Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Branded Generics Market Driver Anlaysis
Fig.6 Branded Generics Market Restraint Analysis
Fig.7 Branded Generics Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Branded Generics Market
Fig.10 Company Market Share Analysis, 2019

Branded Generics Market Segmentation:

Branded Generics Market, By Application (2016-2027)

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Others

Branded Generics Market, By Drug Class (2016-2027)

  • Anti-Hypertensive
  • Antimetabolites
  • Lipid Lowering Drugs
  • Others

Branded Generics Market, By Consumption Type (2016-2027)

  • Oral
  • Parenteral
  • Topical
  • Others

Branded Generics Market, By Distribution Channel (2016-2027)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Pharmacies

Branded Generics Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Branded Generics Market:

  • Zydus Cadila
  • Hetero
  • AstraZeneca
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Aspen Holdings
  • Bausch Health

Lifesciences Limited

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.